In this study, linear and spherical polymeric carrier were examined for synthetic peptide, several examples are given to polymeric carrier and examined immune response and their advantage.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Synthetic peptides that bind to carrier polymer molecules to use recent vaccine technology can create a higher immune response, remain longer in biological systems and they may be more stable against degrading.
📊
Key Findings & Data:In these systems where natural or synthetic polymers can be used; synthetic carriers have more advantage compared to natural carriers such as obtainingproducts with high purity yields, manipulating structure and the molecular weight as desired, creating specific effects with simple additions of various chemical groups to the structure.
💡
Conclusion & Impact:In this study, linear and spherical polymeric carrier were examined for synthetic peptide, several examples are given to polymeric carrier and examined immune response and their advantage.
Synthetic peptides that bind to carrier polymer molecules to use recent vaccine technology can create a higher immune response, remain longer in biological systems and they may be more stable against degrading. This is why synthetic peptides are given to living systems either by creating a microatmosphere or a conjugate. In these systems where natural or synthetic polymers can be used; synthetic carriers have more advantage compared to natural carriers such as obtainingproducts with high purity yields, manipulating structure and the molecular weight as desired, creating specific effects with simple additions of various chemical groups to the structure. In this study, linear and spherical polymeric carrier were examined for synthetic peptide, several examples are given to polymeric carrier and examined immune response and their advantage.
Büyüktanır Ö.,“Günümüzde Biyoteknolojik Bakteriyel Aşılar”, Atatürk Üniversitesi Vet. Bil. Derg.5 (2): 97-105, 2010
Altınsoy N., “Aşı Üretim Teknikleri ve Kontrolü”, A.Ü. Veteriner Fakültesi, Mikrobiyoloji Anabilim Dalı, Ankara, 2007
Skwarczynski M., Toth I., “Peptide-based synthetic vaccines”, Chemical Science, 7:2- 842-854, 2016
Kahraman G., “Bor nötron yakalama terapisi için bor içeren polimerik taşıyıcı tasarımı ve hücre kültürlerinde kullanımları”, Hacettepe Üniversitesi FBE Kimya Mühendisliği Anabilimdalı Yükssek lisans tezi, 2004
Varypataki E.M., et.al., “Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles”, Journal of Controlled Release, 226: 98–106, 2016. [7] [Internet] Available from; “http://www.diss.fuberlin.de/diss/servlets/MCRFileNodeServlet/FUDISS_derivate_000000001958/1_Chapte r1Introduction.pdf?hosts=” [accessed 15.05.2015]
Muhamad I., et.al., “Designing Polymeric Nanoparticles for Targeted Drug Delivery System”, Nanomedicine, 287
Janssen M., et.al., Drugs and Polymers for Delivery Systems in OA Joints: Clinical Needs and Opportunities, Polymers, 6(3), 799-819, 2014
Rebouças J., Esparza I., et.al., “Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy”, Journal of Biomedicine and Biotechnology,10.1155/2012/474605, 2012
Şengel-Türk T., Hasçicek C., “Polimerik Nanopartiküler İlaç Taşıyıcı Sistemlerde Yüzey Modifikasyonu”, Ankara Ecz. Fak. Derg., 38 (2) 137-154, 2009
Öner F., “Nanopartiküller:Kolloidal Katı İlaç Taşıyıcı Sistemler”, FABAD 8:250-260, 1983
Fattal E., “Nanoparticle and liposomes for drug targetting”, Berlin, pp 1-4, 1997
S. Gomez C. Gamazo, B. S. Roman, M. Ferrer, M. L. Sanz, and J.M. Irache, “Gantrez_AN nanoparticles as an adjuvant for oral immunotherapy with allergens,” Vaccine, vol. 25, no. 29, pp. 5263–5271, 2007
Correia-Pintoa J.F., Csaba N., Alonso M. J., “Vaccine delivery carriers: Insights and future perspective”, International Journal of Pharmaceutics 440 (2013) 27– 38, 2012
Powell S.B., Andrianov A.K., Fusco P.C., “Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes”, Clin Exp Vaccine Res, 4:23-45, 2015